A multicenter study of the HeartWare ventricular assist device in small children

Abstract

Continuous-flow ventricular assist devices (CF-VADs), designed for patients with a body surface area (BSA) ≥1.2 m2, have improved survival free from stroke and device failure in adults compared with pulsatile devices. Initial experiences in larger children with these CF-VADs have been promising; however, a large proportion of children needing long-term support as a bridge to heart transplantation (HTx) have a BSA of ≤1 m2. These small children can be successfully supported with paracorporeal pulsatile devices, yet rates of thromboembolic events continue to be an ongoing concern.

Read More

Citation
Miera O, Kirk R, Buchholz H, et al. J Heart Lung Transplant 2016;35:679–81.